BUDZ Stock Overview
WEED, Inc., together with its subsidiaries, focuses on the development and application of cannabis-derived compounds for the treatment of human diseases and animal ailments.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
WEED, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.073 |
52 Week High | US$0.15 |
52 Week Low | US$0.05 |
Beta | 0.94 |
1 Month Change | -7.25% |
3 Month Change | 7.49% |
1 Year Change | 4.41% |
3 Year Change | -90.12% |
5 Year Change | -92.87% |
Change since IPO | -51.27% |
Recent News & Updates
Recent updates
Shareholder Returns
BUDZ | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | -6.4% | -0.2% | 0.6% |
1Y | 4.4% | 23.9% | 29.5% |
Return vs Industry: BUDZ underperformed the US Pharmaceuticals industry which returned 23.1% over the past year.
Return vs Market: BUDZ underperformed the US Market which returned 29.8% over the past year.
Price Volatility
BUDZ volatility | |
---|---|
BUDZ Average Weekly Movement | 12.7% |
Pharmaceuticals Industry Average Movement | 9.5% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.9% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BUDZ has not had significant price volatility in the past 3 months.
Volatility Over Time: BUDZ's weekly volatility has decreased from 19% to 13% over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 2 | Glenn Martin | https://weedincusa.com |
WEED, Inc., together with its subsidiaries, focuses on the development and application of cannabis-derived compounds for the treatment of human diseases and animal ailments. It is involved in the cultivation and harvesting cannabis and hemp for research, product development, processing, manufacturing, and sale of pharmaceutical and non-pharmaceutical products, services, therapeutics, and treatments for the medical applications. The company was formerly known as United Mines, Inc. and changed its name to WEED, Inc. in February 2015.
WEED, Inc. Fundamentals Summary
BUDZ fundamental statistics | |
---|---|
Market cap | US$8.95m |
Earnings (TTM) | -US$492.63k |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-18.3x
P/E RatioIs BUDZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BUDZ income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | -US$2.23k |
Gross Profit | US$2.23k |
Other Expenses | US$494.86k |
Earnings | -US$492.63k |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.004 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 24.0% |
How did BUDZ perform over the long term?
See historical performance and comparison